KYMR logo

Kymera Therapeutics, Inc. (KYMR) CAPEX

Annual CAPEX:

$12.84M-$21.64M(-62.77%)
December 31, 2024

Summary

  • As of today, KYMR annual capital expenditures is $12.84 million, with the most recent change of -$21.64 million (-62.77%) on December 31, 2024.
  • During the last 3 years, KYMR annual CAPEX has risen by +$11.24 million (+703.88%).
  • KYMR annual CAPEX is now -62.77% below its all-time high of $34.48 million, reached on December 31, 2023.

Performance

KYMR CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

Quarterly CAPEX:

$181.00K-$514.00K(-73.96%)
September 30, 2025

Summary

  • As of today, KYMR quarterly capital expenditures is $181.00 thousand, with the most recent change of -$514.00 thousand (-73.96%) on September 30, 2025.
  • Over the past year, KYMR quarterly CAPEX has dropped by -$8000.00 (-4.23%).
  • KYMR quarterly CAPEX is now -98.44% below its all-time high of $11.63 million, reached on December 31, 2023.

Performance

KYMR Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

TTM CAPEX:

$2.28M-$8000.00(-0.35%)
September 30, 2025

Summary

  • As of today, KYMR TTM capital expenditures is $2.28 million, with the most recent change of -$8000.00 (-0.35%) on September 30, 2025.
  • Over the past year, KYMR TTM CAPEX has dropped by -$21.63 million (-90.47%).
  • KYMR TTM CAPEX is now -93.98% below its all-time high of $37.87 million, reached on March 31, 2024.

Performance

KYMR TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

KYMR CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-62.8%-4.2%-90.5%
3Y3 Years+703.9%-85.5%-23.1%
5Y5 Years+2313.2%-92.5%-71.0%

KYMR CAPEX Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-62.8%+703.9%-98.4%at low-94.0%at low
5Y5-Year-62.8%+2313.2%-98.4%+10.4%-94.0%+42.7%
All-TimeAll-Time-62.8%+2313.2%-98.4%+10.4%-94.0%+1045.2%

KYMR CAPEX History

DateAnnualQuarterlyTTM
Sep 2025
-
$181.00K(-74.0%)
$2.28M(-0.3%)
Jun 2025
-
$695.00K(+48.8%)
$2.29M(-63.6%)
Mar 2025
-
$467.00K(-50.1%)
$6.28M(-52.5%)
Dec 2024
$12.84M(-62.8%)
$936.00K(+395.2%)
$13.22M(-44.7%)
Sep 2024
-
$189.00K(-96.0%)
$23.91M(-24.8%)
Jun 2024
-
$4.69M(-36.7%)
$31.79M(-16.1%)
Mar 2024
-
$7.40M(-36.3%)
$37.87M(+9.8%)
Dec 2023
$34.48M(+1115.8%)
$11.63M(+43.9%)
$34.48M(+48.4%)
Sep 2023
-
$8.08M(-25.0%)
$23.23M(+41.7%)
Jun 2023
-
$10.77M(+168.6%)
$16.40M(+157.7%)
Mar 2023
-
$4.01M(+974.8%)
$6.36M(+124.4%)
Dec 2022
$2.84M
$373.00K(-70.1%)
$2.84M(-4.3%)
DateAnnualQuarterlyTTM
Sep 2022
-
$1.25M(+69.5%)
$2.96M(+46.4%)
Jun 2022
-
$735.00K(+52.5%)
$2.02M(+5.7%)
Mar 2022
-
$482.00K(-3.8%)
$1.92M(+19.9%)
Dec 2021
$1.60M(-82.4%)
$501.00K(+63.7%)
$1.60M(-37.0%)
Sep 2021
-
$306.00K(-51.1%)
$2.53M(-45.4%)
Jun 2021
-
$626.00K(+281.7%)
$4.64M(-41.1%)
Mar 2021
-
$164.00K(-88.6%)
$7.87M(-13.5%)
Dec 2020
$9.10M(+1609.8%)
$1.44M(-40.3%)
$9.10M(+15.8%)
Sep 2020
-
$2.41M(-37.5%)
$7.86M(+44.2%)
Jun 2020
-
$3.85M(+176.3%)
$5.45M(+241.8%)
Mar 2020
-
$1.40M(+601.0%)
$1.59M(+701.0%)
Dec 2019
$532.00K(-60.8%)
$199.00K
$199.00K
Dec 2018
$1.36M
-
-

FAQ

  • What is Kymera Therapeutics, Inc. annual capital expenditures?
  • What is the all-time high annual CAPEX for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. annual CAPEX year-on-year change?
  • What is Kymera Therapeutics, Inc. quarterly capital expenditures?
  • What is the all-time high quarterly CAPEX for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. quarterly CAPEX year-on-year change?
  • What is Kymera Therapeutics, Inc. TTM capital expenditures?
  • What is the all-time high TTM CAPEX for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. TTM CAPEX year-on-year change?

What is Kymera Therapeutics, Inc. annual capital expenditures?

The current annual CAPEX of KYMR is $12.84M

What is the all-time high annual CAPEX for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high annual capital expenditures is $34.48M

What is Kymera Therapeutics, Inc. annual CAPEX year-on-year change?

Over the past year, KYMR annual capital expenditures has changed by -$21.64M (-62.77%)

What is Kymera Therapeutics, Inc. quarterly capital expenditures?

The current quarterly CAPEX of KYMR is $181.00K

What is the all-time high quarterly CAPEX for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high quarterly capital expenditures is $11.63M

What is Kymera Therapeutics, Inc. quarterly CAPEX year-on-year change?

Over the past year, KYMR quarterly capital expenditures has changed by -$8000.00 (-4.23%)

What is Kymera Therapeutics, Inc. TTM capital expenditures?

The current TTM CAPEX of KYMR is $2.28M

What is the all-time high TTM CAPEX for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high TTM capital expenditures is $37.87M

What is Kymera Therapeutics, Inc. TTM CAPEX year-on-year change?

Over the past year, KYMR TTM capital expenditures has changed by -$21.63M (-90.47%)
On this page